# Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions

> **NCT00851162** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Bone Neoplasms

## Interventions

- **BIOLOGICAL:** Trinity multipotent stem cells
- **BIOLOGICAL:** Demineralized bone matrix(DBM)

## Key facts

- **NCT ID:** NCT00851162
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not continued due to lack of enrollment.
- **Last updated:** 2012-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00851162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00851162, "Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00851162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*